Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Invested Capital (2024 - 2025)

Krystal Biotech's Return on Invested Capital history spans 2 years, with the latest figure at 0.15% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 8.0% year-over-year to 0.15%; the TTM value through Dec 2025 reached 0.15%, up 8.0%, while the annual FY2025 figure was 0.16%, 9.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.15% at Krystal Biotech, down from 0.15% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.15% in Q3 2025 and bottomed at 0.02% in Q2 2024.